Acurx Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).
Acurx Pharmaceuticals has raised $7.1M across 1 funding round on record, the most recent an undisclosed round of $7.1M announced in Apr 2026.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Acurx Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Acurx Pharmaceuticals Funding Rounds
Acurx Pharmaceuticals Founders and Leadership Team
Contact details for the Acurx Pharmaceuticals team: 1 of 1 has an email address on file.
Start 14-day free trial →Acurx Pharmaceuticals Funding Compared to Other Health Care Startups
Acurx Pharmaceuticals' latest round of $7.1M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Acurx Pharmaceuticals in Health Care and White Plains
Companies Similar to Acurx Pharmaceuticals
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Acurx Pharmaceuticals Funding FAQs
What does Acurx Pharmaceuticals do?
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections. The Company's approach is to develop antibiotic candidates that target the DNA polymerase IIIC enzyme and its R&D pipeline includes early stage antibiotic candidates that target other Gram-positive bacteria, including Methicillin-Resistant Staphylococcus aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Penicillin-Resistant Streptococcus pneumoniae (PRSP).
How much funding has Acurx Pharmaceuticals raised?
Acurx Pharmaceuticals has raised $7.1M across 1 round on record. The most recent is an undisclosed round of $7.1M announced in Apr 2026.
When did Acurx Pharmaceuticals last raise funding?
Acurx Pharmaceuticals' most recent funding round on record is an undisclosed round of $7.1M, announced in Apr 2026.
Who founded Acurx Pharmaceuticals?
FundedIQ lists David Luci (Founder) at Acurx Pharmaceuticals.
Where is Acurx Pharmaceuticals headquartered?
Acurx Pharmaceuticals is based in White Plains, New York, United States.
How many employees does Acurx Pharmaceuticals have?
Acurx Pharmaceuticals is in the 11-50 employee band.
How does Acurx Pharmaceuticals' funding compare to other Health Care startups?
Acurx Pharmaceuticals' latest round of $7.1M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Acurx Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Acurx Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.